| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 30.41B | 28.45B | 25.80B | 19.58B | 25.80B |
| Gross Profit | 6.59B | 5.57B | 5.23B | -104.30M | 12.27B |
| EBITDA | 8.05B | 7.04B | 7.31B | 6.03B | 5.84B |
| Net Income | 4.77B | 3.87B | 4.38B | 3.37B | 3.40B |
Balance Sheet | |||||
| Total Assets | 107.59B | 96.78B | 91.99B | 92.13B | 86.65B |
| Cash, Cash Equivalents and Short-Term Investments | 11.68B | 7.28B | 7.96B | 11.70B | 25.34B |
| Total Debt | 14.83B | 13.06B | 10.80B | 9.32B | 7.75B |
| Total Liabilities | 76.77B | 68.43B | 64.28B | 71.79B | 65.33B |
| Stockholders Equity | 26.47B | 24.07B | 22.95B | 16.68B | 16.39B |
Cash Flow | |||||
| Free Cash Flow | 2.40B | 3.59B | -553.50M | -4.84B | 6.29B |
| Operating Cash Flow | 2.99B | 3.99B | -39.40M | -4.42B | 6.64B |
| Investing Cash Flow | -702.28M | -1.32B | 92.00M | 384.80M | 1.84B |
| Financing Cash Flow | -1.69B | -1.56B | -1.07B | -1.29B | -1.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$43.89B | 15.12 | 16.27% | 1.86% | 2.51% | 44.44% | |
72 Outperform | C$50.69B | 8.56 | 18.62% | 0.84% | 10.08% | 24.18% | |
72 Outperform | C$49.02B | 12.88 | 14.68% | 4.11% | -19.88% | -13.92% | |
72 Outperform | C$14.18B | 15.09 | 13.62% | 2.11% | -25.13% | 16.40% | |
68 Neutral | C$7.69B | 21.30 | 11.01% | 0.98% | 19.80% | -12.93% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | C$59.66B | 14.06 | 13.98% | 3.62% | -20.64% | 14.88% |